For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...

But a new study looking at the anti-amyloid drug gantenerumab could change all that. Published in the Lancet Neurology ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

New research suggests that blood tests used to diagnose Alzheimer's disease have racial disparities. Here's what's going on ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

An experimental Alzheimer's treatment from Boston researchers may be able to treat both dementia and depression symptoms.

An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now caught ...

Alzheimer's disease progresses gradually, with subtle behavioral changes often appearing long before a formal diagnosis.